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Abstract
Background: Skeletal muscle atrophy commonly occurs in critically ill patients, and decreased muscle mass is
associated with worse clinical outcomes. Muscle mass can be assessed using various tools, including ultrasound and
bioelectrical impedance analysis (BIA). However, the effectiveness of muscle mass monitoring is unclear in critically
ill patients. This study was conducted to compare ultrasound and BIA for the monitoring of muscle mass in critically
ill patients.
Methods: We recruited adult patients who were expected to undergo mechanical ventilation for > 48 h and to
remain in the intensive care unit (ICU) for > 5 days. On days 1, 3, 5, 7, and 10, muscle mass was evaluated using an
ultrasound and two BIA devices (Bioscan: Malton International, England; Physion: Nippon Shooter, Japan). The
influence of fluid balance was also evaluated between each measurement day.
Results: We analyzed 93 images in 21 patients. The age of the patients was 69 (interquartile range, IQR, 59–74)
years, with 16 men and 5 women. The length of ICU stay was 11 days (IQR, 9–25 days). The muscle mass, monitored
by ultrasound, decreased progressively by 9.2% (95% confidence interval (CI), 5.9–12.5%), 12.7% (95% CI, 9.3–16.1%),
18.2% (95% CI, 14.7–21.6%), and 21.8% (95% CI, 17.9–25.7%) on days 3, 5, 7, and 10 (p < 0.01), respectively, with no
influence of fluid balance (r = 0.04, p = 0.74). The muscle mass did not decrease significantly in both the BIA devices
(Bioscan, p = 0.14; Physion, p = 0.60), and an influence of fluid balance was observed (Bioscan, r = 0.37, p < 0.01;
Physion, r = 0.51, p < 0.01). The muscle mass assessment at one point between ultrasound and BIA was moderately
correlated (Bioscan, r = 0.51, p < 0.01; Physion, r = 0.37, p < 0.01), but the change of muscle mass in the same
patient did not correlate between these two devices (Bioscan, r = − 0.05, p = 0.69; Physion, r = 0.23, p = 0.07).
Conclusions: Ultrasound is suitable for sequential monitoring of muscle atrophy in critically ill patients. Monitoring
by BIA should be carefully interpreted owing to the influence of fluid change.
Trial registration: UMIN000031316. Retrospectively registered on 15 February 2018.
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Introduction
Skeletal muscle atrophy commonly occurs in critically ill
patients. The muscles of critically ill patients can rapidly
atrophy after admission in the intensive care unit (ICU).
During intensive care, a noticeable reduction in muscle
mass, starts within 3 days and progressively worsens
thereafter [1]. Our previous report suggested that the
upper- and lower-limb muscle mass of intensive care pa-
tients decrease by 13–21% within 7 days of admission
[2]. Moreover, decreased muscle mass is associated with
prolonged weaning from mechanical ventilation and
length of ICU stay, as well as higher mortality [3].
Although monitoring of muscle mass is important,
identification of an optimal method of estimating muscle
mass remains difficult. There are many methods that
can estimate muscle mass. In recent years, the use of
ultrasound and bioelectrical impedance analysis (BIA)
has become more widely accepted in the ICU [4]. A re-
cent study by Kim et al. reported that BIA could be used
for whole-body muscle mass assessment at one point in
critically ill patients [5]. However, sequential muscle
mass monitoring capability of BIA in the same critically
ill patients, not muscle mass assessment at one point,
has not been investigated. Patients in the ICU are gener-
ally under abnormal fluid status. Because BIA indirectly
estimates muscle mass using electrical resistance, and
the resistance is affected by fluid status, the hypothesis
that BIA could not accurately monitor the change of
muscle mass in critically ill patients is reasonable.
This study aimed to compare the use of ultrasound
and BIA for muscle mass monitoring in critically ill pa-
tients. The influence of fluid shift was also analyzed be-
cause edema may complicate these measurements and
few studies cleared the complication. In addition, muscle
mass was retrospectively evaluated using computed tom-
ography (CT) to compare with previous studies.
Materials and methods
Study design and setting
We conducted a prospective observational single-center
study at the mixed medical/surgical ICU of Tokushima
University Hospital from May 2016 to May 2017. This
study was approved by the clinical research ethics com-
mittee at Tokushima University Hospital (approval num-
ber 2593). At enrollment, written informed consent was
obtained from patients or from an authorized surrogate.
Study population
We consecutively recruited adult patients who were ex-
pected to require mechanical ventilation for > 48 h and to
remain in the ICU for > 5 days. The patients were pro-
spectively recruited within 24 h of ICU admission. We ex-
cluded patients who fell under one or more of the
following categories: age younger than 18 years; pregnant;
exhibiting trauma to or amputation of upper or lower
limbs; diagnosed with primary neuromuscular disease;
embedded electronic devices, such as a pacemaker or im-
planted cardiac defibrillator because the current from BIA
could affect the device activity.
Ultrasonographic measurement
For sonography, we used a HI VISION Preirus with B-
mode imaging, which was connected to a 6.5 MHz 3.8-
cm linear transducer (EUP-L73S Features; both Hitachi
Medical Corporation, Tokyo, Japan). All scanning was
performed with patients in the supine position and el-
bows and knees in passive extension. Generous amounts
of contact gel were applied to avoid compression of the
muscles by the transducer. The transducer was placed
perpendicular relative to the long axis of the limbs. The
sum of biceps brachii and rectus femoris cross-sectional
area was used for the comparison because of the im-
proved whole-body muscle mass assessment with the
sum of the upper and lower limb [6]. The cross-
sectional area at the dominant limb was evaluated on
days 1, 3, 5, 7, and 10 (Additional file 1: Figs. S1, S2).
The subcutaneous tissue thickness was also evaluated
for the assessment of edema (Additional file 1: Fig. S2).
The sum of subcutaneous tissue thickness at the biceps
brachii and rectus femoris muscles was used for the as-
sessment. Before commencing the study, the intra- and
inter-observer reproducibilities were 0.93–0.99 and
0.93–0.98, and 0.83–0.99 and 0.90–0.99 for the muscle
and subcutaneous tissue, respectively, as assessed by two
ICU physicians (Additional file 1: Table S1). Therefore,
each measurement was performed by the same investigator.
The investigator performing measurements was not blinded
to patients’ condition, but image analyses were blinded by
concealing patients’ name and measurement days.
Bioelectrical impedance analysis
BIA is a noninvasive tool that measures impedance by
sending a weak electric current through the body. BIA in-
directly estimates body composition, including fat, water,
bone mass, lean body mass, and muscle. BIA was used on
days 1, 3, 5, 7, and 10. Two different BIA devices were
used as follows: Bioscan 920-2 (Malton International,
Essex, United Kingdom) and Physion MD (Nippon
Shooter Ltd., Tokyo, Japan). BIA measurements were also
conducted on days 1, 3, 5, 7, and 10, with the patients in
the supine position with extended limbs and 30° abduc-
tion of the shoulder and hip.
Bioscan 920-2
Bioscan can measure muscle mass by using four to eight
electrodes. We used four electrodes for hemi-lateral upper
and lower extremities. The electrodes were attached to
the dorsum of the wrists and third metacarpi of the hand,
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and the anterior surface of the ankles and third metacarpi
of the foot. Bioscan has multi-frequency measurement (5,
50, 100, and 200 kHz) with low-amplitude current
(700 μA). The range of impedance is 2–1200Ω. The data
obtained included total body water, intracellular water,
extracellular water, and skeletal muscle mass.
Physion MD
Physion MD can measure site-specific muscle mass, in-
cluding the upper arms, forearms, thighs, lower legs, and
trunk by using a four-limb 12-lead electrode. The measur-
ing frequency and current are 50 kHz and 500 μA, respect-
ively. The range of impedance is 10–1500Ω. The data
obtained included total body water (no data regarding
intra- or extracellular water) and skeletal muscle mass.
Computed tomography
We retrospectively evaluated the muscle mass using the
transverse plane in CT because previous studies have
compared the muscle mass assessment between BIA and
CT [5, 7]. CT examinations were performed for clinical
purpose. Therefore, the examination day is not consistent
among included patients. The muscle mass at the L3 spine
level correlates well with whole-body muscle mass. There-
fore, the muscle mass area at L3 was measured by outlin-
ing the muscle area using Image J software (National
Institutes of Health, Bethesda, MD, USA, Additional file 1:
Fig. S3).
Fluid balance
Fluid balance was evaluated during ICU stay because the
fluid status may interfere with the assessment of muscle
mass. Fluid intake included intravenous fluids, total paren-
teral and enteral nutrition, blood products, and intraven-
ous medications. Fluid output included urine, excrement,
blood loss, output from drains and other body cavities,
and gastric aspirate. Other fluid losses, such as sweat and
respiratory evaporation, were excluded. We used fluid bal-
ance from a measurement day to the day before the next
measurement. We compared the fluid balance with the
change of measured variables in the same intervals. Add-
itionally, the change of balance was analyzed from the ad-
mission to each measurement days. Fluid balance was
classified into interval fluid balance between each meas-
urement day or accumulated fluid balance from day 1 to
measurement days (Additional file 1: Fig. S4).
Outcomes
The primary outcome was the time course of muscle at-
rophy, evaluated using ultrasound and two BIA devices.
To assess the changes in muscle mass, we calculated the
atrophy rate, defined as the percent variation of muscle
mass as compared with values on day 1.
The secondary outcome was a comparison of muscle
mass assessment between ultrasound and BIA. We ana-
lyzed the muscle mass assessment at one point and sub-
sequent muscle mass change from day 1 to each study
day. Then, we retrospectively compared these muscle
mass assessment methods with CT evaluation in a lim-
ited number of patients. Finally, we evaluated the associ-
ation of these measurement methods and fluid balance.
Statistical analyses
Mixed-effects models for repeated measures (MMRM)
was used to assess the changes in muscle mass over
time: statistical significance of muscle mass atrophy at
each time point was also tested using 95% confidence in-
tervals (CIs), with intervals excluding zero considered to
be statistically significant. Data were presented as mean
(95% CI). The Pearson correlation coefficient was used
to investigate relationships among measured variables.
Due to the exploratory research, the sample size was not
calculated a priori but determined upon feasible size.
Data analyses were conducted using JMP statistical soft-
ware version 13.1.0 (SAS Institute Inc., Cary, NC, USA).
All statistical tests were two-tailed, and the chosen type
1 error rate was p < 0.05.
Results
Twenty-one patients were enrolled, and all patients par-
ticipated in the study on day 3, 19 patients on day 5, 19
on day 7, and 13 on day 10 (Fig. 1). The age of the pa-
tients was 69 (interquartile range, IQR, 59–74) years,
and 16 patients were men (patient characteristics are
summarized in Table 1). The APACHE II score was 28
(IQR, 23–30). The duration of mechanical ventilation
was 7 days (IQR, 5–18 days). The reasons for admission
were surgical (29%) and non-surgical (71%).
Percentage changes in muscle mass
We analyzed 93 ultrasound images in 21 patients. The
muscle mass decreased progressively by 9.2% (95% CI,
5.9–12.5%), 12.7% (95% CI, 9.3–16.1%), 18.2% (95% CI,
14.7–21.6%), and 21.8% (95% CI, 17.9–25.7%) on days 3,
5, 7, and 10, respectively (p < 0.01; MMRM, Fig. 1). Using
Bioscan, 83 tests in 21 patients were analyzed. Ten tests
were missing data (7 tests were measurement errors and 3
tests were unable to be performed). The muscle mass had
changed by 0.7% (95% CI, − 2.6 to 4.0%), − 4.5% (95% CI,
− 8.1 to − 0.9%), − 1.7% (95% CI, − 5.2 to 1.8%), and −
2.9% (95% CI, − 6.7 to 0.9%) on days 3, 5, 7, and 10, re-
spectively (p = 0.14; MMRM). Using Physion, 8 tests were
missing data (5 tests were measurement errors and 3 tests
were unable to be performed). In 85 measurements, the
muscle mass had changed by 0.7% (95% CI, − 9.4% to
10.9%), − 5.5% (95% CI, − 16.2% to 5.1%), − 5.1% (95% CI,
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− 15.3% to 5.1%), and − 7.7% (95% CI, − 19.6 to 4.3%) on
days 3, 5, 7, and 10, respectively (p = 0.60; MMRM).
Relationship between ultrasound and BIA in muscle mass
evaluation
In muscle mass assessment at one point, BIA was corre-
lated with ultrasound in some examination days (Bioscan,
days 1, 5, 7, and 10; Physion, days 1 and 5, Fig. 2a). In
sum, average correlation was r = 0.51, p < 0.01 in Bioscan
(n = 83) and r = 0.37, p < 0.01 in Physion (n = 85). In con-
trast, the percentage change of muscle mass in BIA did
not correlate with the findings using ultrasound (Fig. 2b).
The average correlation was r = − 0.05, p = 0.69 in Bioscan
(n = 62) and r = 0.23, p = 0.07 in Physion (n = 64).
Relationship among ultrasound, BIA, and CT in muscle
mass evaluation
We analyzed 17 CT images in 17 patients at day 1 and 8
patients with the subsequent examination (1, 2, 3, 2 pa-
tients at days 3, 5, 7, 10). At day 1, ultrasound showed a
strong correlation with CT measurement (r = 0.84,
p < 0.01, Fig. 3a). BIA was moderately correlated with
CT measurement (Bioscan, r = 0.60, p = 0.01; Physion,
r = 0.55, p = 0.02). The percentage change of muscle
mass in CT correlated only with ultrasound (ultrasound,
r = 0.76, p = 0.03; Bioscan, r = − 0.54, p = 0.17; Physion,
r = 0.35, p = 0.39, Fig. 3b).
Relationship against fluid balance
In ultrasound, the percentage change of muscle mass was
not correlated with interval fluid balance in the ICU (r =
0.04, p = 0.74), whereas subcutaneous tissue was corre-
lated with interval fluid balance (r = 0.38, p < 0.01, Table 2,
Fig. 1 Percentage change in muscle mass, monitored by an ultrasound and two BIAs. Percentage change in muscle mass was calculated in the
comparison with the value of day 1. Muscle mass, monitored by an ultrasound, statistically significantly (p < 0.01) decreased, whereas muscle
mass, monitored by two BIAs, did not statistically significantly decrease (Bioscan, p = 0.14; Physion, p = 0.60). p values were derived from mixed-
effects models for repeated measures. Data are presented as means and 95% confidence intervals. The number of patients daily is displayed
below the graph. BIA bioelectrical impedance analysis
Table 1 Patients’ characteristics (n = 21)
Variables Overall
Age, years 69 (59–74)
Gender (men), n (%) 16 (76%)
Body mass index, kg/m2 (mean (SD)) 22.9 ± 3.8
APACHE II score 28 (23–30)
ICU length of stay, days 11 (9–25)
Duration of mechanical ventilation, days 7 (5–18)
Hospital length of stay, days 43 (26–117)
Mortality in the ICU, n (%) 6 (29%)
ICU admission reasons
Surgical, n (%) 6 (29%)
Non-surgical, n (%) 15 (71%)
Data were presented as median (IQR) unless otherwise indicated. SD standard
deviation, APACHE Acute Physiology and Chronic Health Evaluation, ICU
intensive care unit, IQR interquartile range
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Fig. 2 Relationship between ultrasound and BIA in muscle mass evaluation. The correlation between ultrasound and two BIAs. a Muscle mass. b
Muscle mass change. a Muscle mass was compared at one point in each measurement day. BIA was correlated with ultrasound in some
measurement days (Bioscan, days 1, 5, 7, and 10; Physion, days 1 and 5). b Muscle mass change was compared from day 1 to each measurement
day. The percentage change of muscle mass in BIA did not correlate with the findings using ultrasound. The correlations were shown under
every graph. Pearson correlation coefficient was used to investigate the relationships. BIA bioelectrical impedance analysis
Fig. 3 Relationship among ultrasound, BIA, and CT in muscle mass evaluation. The correlation among ultrasound, BIA, and CT. a Muscle mass. b
Muscle mass change. a Muscle mass was compared in 17 patients at day 1. Both ultrasound and BIA were correlated with CT measurements. b
Muscle mass change was compared from day 1 to each measurement day (1, 2, 3, and 2 patients at days 3, 5, 7, and 10). Ultrasound, not BIA, was
correlated with CT measurements. The correlations were shown under both graphs. Pearson correlation coefficient was used to investigate the
relationships. BIA bioelectrical impedance analysis, CT computed tomography
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Additional file 1: Fig. S5). The measurements of BIA and
body weight change were positively correlated with inter-
val fluid balance (r = 0.34–0.57, p < 0.01). In accumulated
fluid balance, fluid shift and body weight were also corre-
lated (r = 0.29–0.57, p ≦ 0.02, Additional file 1: Fig. S6). In
ultrasound, the change of muscle mass was not correlated
with accumulated fluid balance in the ICU (r = 0.16, p =
0.18), and subcutaneous tissue was also not correlated with
accumulated fluid balance (r = 0.20, p = 0.09). Furthermore,
the muscle mass assessment of Bioscan was not correlated
with accumulated fluid balance, (r = 0.15, p = 0.25), al-
though it was correlated at day 3 (r = 0.69, p < 0.01).
Discussion
In this observational study, we found muscle mass moni-
toring by BIA was complicated by the fluid shift and
could not monitor the change of muscle mass in critic-
ally ill patients, although muscle mass assessment at one
point moderately correlated with ultrasound and CT. In
contrast, the use of ultrasound monitored progressive
muscle atrophy over the ICU stay without the influence
of fluid shift. To our knowledge, this is the first study to
investigate muscle mass monitoring capacity by BIA and
ultrasound with the assessment of fluid balance.
In our study, the reference standard of muscle mass
evaluation was based on ultrasound. The accuracy of
muscle mass evaluation by ultrasound has been estab-
lished in many researches [1, 8]. In this study, days over
ICU stay resulted in an atrophy rate similar to the one
previously reported (21.8% on day 10 in our study vs.
17.7% in Puthucheary’s study, and vs. 29.9% in Parry’s
study) [1, 8]. Furthermore, we found that muscle mass
assessment by ultrasound was strongly correlated with
CT (r = 0.76–0.84, p ≤ 0.03). Because CT can separate
muscle, fat, and other tissues, CT is considered as an
accurate and precise method for muscle mass assess-
ment [9]. Therefore, the value of ultrasound assessment
is reliable.
In a previous study, Kim et al. found that muscle mass
assessment by using BIA correlated with CT assessment
(n = 135, r = 0.58–0.73, p < 0.0001), suggesting that BIA
can be used for muscle mass assessment of critically ill
patients [5]. Another previous study by Kuchnia et al. re-
ported that phase angle and impedance ratio measured
by BIA correlated with muscle mass in CT (n = 71, r =
0.67–0.78, p < 0.05) [7]. Consistent with these findings,
muscle mass assessment by BIA was moderately corre-
lated at one point in our study. However, no study inves-
tigated the usefulness of BIA for the muscle mass
monitoring in the same critically ill patients. Hosono
et al. successfully used BIA for follow-up measurements
of muscle mass with rheumatologic patients [10], but its
use in critically ill patients is still unknown because pa-
tients in the ICU are exposed to abnormal fluid status.
In the edematous condition, the use of BIA for muscle
mass monitoring may overestimate the muscle mass in
critically ill patients. In a previous study by Kim et al., BIA
measurement was complicated by edema and overesti-
mated muscle mass in critically ill patients. Extracellular-
to-total body water (ECW/TBW) is often used for the
assessment of edema with the cutoff value of 0.40 [11]. In
this study, the median extracellular-to-total body water
(ECW/TBW) was 0.48 (IQR, 0.46–0.51). Similarly, in pre-
vious reports, most critically ill patients had increased
amount of extracellular fluid [5, 11]. Therefore, the results
of BIA for muscle mass monitoring should be carefully
interpreted in critically ill patients.
However, the estimation of muscle mass may differ
among BIA devices [12]. In this two-device comparison
study, Physion was possibly more influenced by fluid
Table 2 Relationship against fluid balance (interval and accumulated)
Percentage change (%) Interval Accumulated
n r p value n r p value
Muscle mass
Ultrasound 72 0.04 0.74 72 0.16 0.18
BIA (Bioscan) 55 0.37 < 0.01 62 0.15 0.25*
BIA (Physion) 60 0.51 < 0.01 64 0.45 < 0.01
Subcutaneous tissue by ultrasound 72 0.38 < 0.01 72 0.20 0.09
Fluid shift measured by BIA (Bioscan) 55 0.56 < 0.01 62 0.56 < 0.01
Extracellular water 55 0.55 < 0.01 62 0.57 < 0.01
Intracellular water 55 0.47 < 0.01 62 0.29 0.02
Fluid shift measured by BIA (Physion) 60 0.34 < 0.01 64 0.34 < 0.01
Body weight 67 0.57 < 0.01 65 0.43 < 0.01
Interval: all variables are the changes (%) between each measurement day. Accumulated: all variables are the changes (%) from day 1 to measurement days. The
Pearson correlation coefficient was used to investigate the relationships. BIA bioelectrical impedance analysis
*The correlation of Bioscan was significant only at day 3 (r = 0.69, p < 0.01 at day 3, r = − 0.06, p = 0.83 at day 5, r = 0.18, p = 0.51 at day 7, r = − 0.12, p = 0.71 at
day 10)
Nakanishi et al. Journal of Intensive Care            (2019) 7:61 Page 6 of 8
balance because it had greater CI (Fig. 1) and higher cor-
relation with fluid balance than Bioscan (Physion, r =
0.45–0.51; Bioscan, r = 0.15–0.37). In Bioscan, the
muscle mass assessment was not influenced by accumu-
lated fluid balance at the later stage in the ICU. We can-
not conclude our results can be applied to all the BIA
devices because Inbody S10 (InBody Corp, South Korea)
or MF-BIA QuadScan 4000 (Bodystas LTD, United
Kingdom) were used in previous studies [5, 7].
Edema is also of concern for the muscle mass evaluation
by ultrasound. Intramuscular edema may complicate
muscle mass evaluation. In our study, the interval fluid
balance affected subcutaneous thickness and did not affect
the muscle mass significantly, implying that the increased
amount of water may increase extracellular water and ac-
cumulate in the subcutaneous tissue. Cartwright’s study,
the thickness of subcutaneous tissue increased over the
ICU stay, and the results indicated that the ultrasound of
the subcutaneous tissue may detect edema in ICU patients
[13]. Similarly, Campbell found muscle thickness corre-
lated with fat-free mass in edematous patients, and specu-
lated that most fluid was not retained in the body of
muscle [14]. In our research, subcutaneous thickness was
associated with interval fluid balance, not accumulated
fluid balance. In prolonged ICU stay, subcutaneous tissue
thickness is influenced by the change of adipose tissue and
muscle mass. Therefore, interval fluid balance was more
sensible to the change of edema. Although the influence
of edema needs further investigation, our results indicate
that ultrasound is suitable for the muscle mass monitoring
in edematous critically ill patients.
There are advantages and limitations among measure-
ment methods. CT, MRI, and dual-energy X-ray absorp-
tiometry may be more accurate in evaluating muscle
mass, but critically ill patients need to be transferred to
the examination room with some risks to perform these
methods. In contrast, ultrasound and BIA can be used
noninvasively at the bedside. Because BIA does not need
measurement skills and can easily be used by any oper-
ator, it is clinically useful if we can apply the device for
muscle mass monitoring. However, the result of this
study was contrary to the use for monitoring. We may
need to clarify some formula to use BIA in critically ill
patients because muscle mass estimation was derived
from healthy volunteers in most BIAs [15]. Conclusively,
in our research, ultrasound was more useful for muscle
mass monitoring in the ICU although it will need meas-
urement skill for accurate measurements. Acquisition of
ultrasound measurement skill may be necessary for
muscle mass monitoring for better nutritional and meta-
bolic support during critical illness.
Our findings suggest that it is worthwhile to use ultra-
sound for muscle mass monitoring. Although BIA may be
useful to assess muscle mass at one point, the results of
BIA for muscle mass monitoring should be carefully inter-
preted in critically ill patients. To improve nutritional sup-
port and rehabilitation, further evidence is needed for the
monitoring of muscle mass in critically ill patients.
Limitations
Our study has several limitations. First, the study has a
small sample size in a single center. Particularly, the num-
ber of CT scan was limited due to the retrospective nature
to avoid extra radiation exposure; consequently, our ob-
servations need to be validated by study of a larger popu-
lation. Second, some data on BIA measurement were
missing mostly due to the measurement error, whereas
ultrasound measurement did not have missing data.
Conclusions
We evaluated muscle mass monitoring methods in critically
ill patients and found that ultrasound is suitable for sequen-
tial monitoring of muscle atrophy. Monitoring by BIA
should be carefully interpreted due to the fluid change.
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Additional file 1: Table S1. Reproducibility of measurements. Figure
S1. Ultrasound sites for the upper and lower limbs. (a) Biceps brachii
muscle was measured at two-thirds of the way between the acromion
and the antecubital crease. (b) Rectus femoris muscle was measured at
midway between the anterior superior iliac spine and the proximal end
of the patella. Figure S2. Ultrasound image of muscle and subcutaneous
tissue. (a) The cross-sectional area of biceps brachii was measured by out-
lining the muscle area shown in the transverse plane. (b) The cross-
sectional area of rectus femoris was measured by outlining the muscle
area shown in the transverse plane. (c) Subcutaneous tissue thickness of
biceps brachii was defined as depth between the skin and the superficial
fascia of the biceps brachii muscle. (d) Subcutaneous tissue thickness of
rectus femoris was defined as depth between the skin and the superficial
fascia of the rectus femoris muscle. Figure S3. CT image of muscle.
Muscle mass area was evaluated from computed tomography at the L3
spine level by using image J software (National Institutes of health, Be-
thesda, MD, USA). Figure S4. Fluid balance calculation. The upper side
depicts interval fluid balance between measurement days. On the other
hand, the lower side depicts accumulated fluid balance from day 1 to
measurement days. Figure S5. Relationship between measurements and
interval fluid balance. Interval fluid balance was compared with variable
measurements between each measurement day. Figure S6. Relationship
between measurements and accumulated fluid balance. Accumulated
fluid balance was compared with variable measurements from day 1 to
measurement days.
Abbreviations
APACHE II: Acute physiology and chronic health evaluation II;
BIA: Bioelectrical impedance analysis; CI: Confidence interval; CT: Computed
tomography; ECW: Extracellular water; ICU: Intensive care unit;
IQR: Interquartile range; MMRM: Mixed-effects models for repeated measures;
MRI: Magnetic resonance imaging; TBW: Total body water
Acknowledgements
Not applicable.
Nakanishi et al. Journal of Intensive Care            (2019) 7:61 Page 7 of 8
Authors’ contributions
NN was involved in study design, analysis and interpretation of the data, and
drafting of the manuscript. TR took part in study design, acquisition of the
data, and analysis. OY provided statistical advice on study design and
analyzed the data. TT and UY were involved in acquisition of the data. IT did
analyze and interpreted the data. TY took part in study design and drafting
of the manuscript. SH took part in the concept and interpretation of the
data. OJ took part in study design, analysis, and drafting of the manuscript.
All authors read and approved the final manuscript.
Funding
This research did not receive any specific grant from funding agencies in the
public, commercial, or not-for-profit sectors.
Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
Ethics approval was obtained from the clinical research ethics committee at
Tokushima University Hospital (approval number 2593). Informed consent to





The authors declare that they have no competing interests.
Author details
1Emergency and Critical Care Medicine, Tokushima University Hospital, 2-50-1
Kuramoto, Tokushima 770-8503, Japan. 2Department of Nutrition and
Metabolism, Tokushima University Graduate School of Biomedical Sciences,
3-18-15 Kuramoto, Tokushima 770-8503, Japan. 3Clinical Trial Center for
Developmental therapeutics, Tokushima University Hospital, 2-50-1
Kuramoto, Tokushima 770-8503, Japan. 4Department of Anesthesiology and
Critical Care, Hiroshima University, 1-2-3 Kasumi, Hiroshima 734-8551, Japan.
5Emergency and Disaster Medicine, Tokushima University Hospital, 2-50-1
Kuramoto, Tokushima 770-8503, Japan.
Received: 16 May 2019 Accepted: 21 November 2019
References
1. Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P,
Hopkinson NS, Phadke R, Dew T, Sidhu PS, et al. Acute skeletal muscle
wasting in critical illness. JAMA. 2013;310(15):1591–600.
2. Nakanishi N, Oto J, Tsutsumi R, Iuchi M, Onodera M, Nishimura M. Upper
and lower limb muscle atrophy in critically ill patients: an observational
ultrasonography study. Intensive Care Med. 2018;44(2):263–4.
3. Weijs PJ, Looijaard WG, Dekker IM, Stapel SN, Girbes AR, Oudemans-van Straaten
HM, Beishuizen A. Low skeletal muscle area is a risk factor for mortality in
mechanically ventilated critically ill patients. Crit Care. 2014;18(2):R12.
4. Looijaard W, Molinger J, Weijs PJM. Measuring and monitoring lean body
mass in critical illness. Curr Opin Crit Care. 2018;24(4):241–7.
5. Kim D, Sun JS, Lee YH, Lee JH, Hong J, Lee JM. Comparative assessment of
skeletal muscle mass using computerized tomography and bioelectrical
impedance analysis in critically ill patients. Clin Nutr. 2019;38(6):2747–55.
6. Paris MT, Lafleur B, Dubin JA, Mourtzakis M. Development of a bedside
viable ultrasound protocol to quantify appendicular lean tissue mass. J
Cachexia Sarcopenia Muscle. 2017;8(5):713–26.
7. Kuchnia A, Earthman C, Teigen L, Cole A, Mourtzakis M, Paris M, Looijaard W,
Weijs P, Oudemans-van Straaten H, Beilman G, et al. Evaluation of bioelectrical
impedance analysis in critically ill patients: results of a multicenter prospective
study. JPEN J Parenter Enteral Nutr. 2017;41(7):1131–8.
8. Parry SM, El-Ansary D, Cartwright MS, Sarwal A, Berney S, Koopman R,
Annoni R, Puthucheary Z, Gordon IR, Morris PE, et al. Ultrasonography in the
intensive care setting can be used to detect changes in the quality and
quantity of muscle and is related to muscle strength and function. J Crit
Care. 2015;30(5):1151 e9–14.
9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin
FC, Michel JP, Rolland Y, Schneider SM, et al. Sarcopenia: European
consensus on definition and diagnosis: report of the European working
group on sarcopenia in older people. Age Ageing. 2010;39(4):412–23.
10. Hosono O, Yoshikawa N, Shimizu N, Kiryu S, Uehara M, Kobayashi H,
Matsumiya R, Kuribara A, Maruyama T, Tanaka H. Quantitative analysis of
skeletal muscle mass in patients with rheumatic diseases under
glucocorticoid therapy—comparison among bioelectrical impedance
analysis, computed tomography, and magnetic resonance imaging. Mod
Rheumatol. 2015;25(2):257–63.
11. Malbrain ML, Huygh J, Dabrowski W, De Waele JJ, Staelens A, Wauters J. The
use of bio-electrical impedance analysis (BIA) to guide fluid management,
resuscitation and deresuscitation in critically ill patients: a bench-to-bedside
review. Anaesthesiol Intensive Ther. 2014;46(5):381–91.
12. Wang JG, Zhang Y, Chen HE, Li Y, Cheng XG, Xu L, Guo Z, Zhao XS, Sato T, Cao
QY, et al. Comparison of two bioelectrical impedance analysis devices with
dual energy X-ray absorptiometry and magnetic resonance imaging in the
estimation of body composition. J Strength Cond Res. 2013;27(1):236–43.
13. Cartwright MS, Kwayisi G, Griffin LP, Sarwal A, Walker FO, Harris JM, Berry MJ,
Chahal PS, Morris PE. Quantitative neuromuscular ultrasound in the
intensive care unit. Muscle Nerve. 2013;47(2):255–9.
14. Campbell IT, Watt T, Withers D, England R, Sukumar S, Keegan MA, Faragher
B, Martin DF. Muscle thickness, measured with ultrasound, may be an
indicator of lean tissue wasting in multiple organ failure in the presence of
edema. Am J Clin Nutr. 1995;62(3):533–9.
15. Miyatani M, Kanehisa H, Masuo Y, Ito M, Fukunaga T. Validity of estimating limb
muscle volume by bioelectrical impedance. J Appl Physiol. 2001;91(1):386–94.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Nakanishi et al. Journal of Intensive Care            (2019) 7:61 Page 8 of 8
